Skip to content

Clinical trials

Completed Dyslipidemias trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Status: Completed Country / region: Germany Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20054
200611
20072
20082
20092
20101
20123
20132
20141
20161
20172
20181
20201
20211
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda11
Kowa Research Europe6
Amgen2
Eli Lilly and Company2
GWT-TUD GmbH2
Novartis2
89bio, Inc.1
Abbott1
Akcea Therapeutics1
Amarin Pharma Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias41
Diabetes Mellitus, Type 212
Hypercholesterolemia12
Diabetes Mellitus10
Glucose Metabolism Disorders10
Hyperlipidemias6
Cardiovascular Diseases5
Atherosclerosis4
Diabetes Mellitus, Lipoatrophic4
Metabolic Diseases3

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.